Drugs Manufacturing License Allocation (DMLA): An Effective Tool for e-Governance in fields of Drugs Manufacturing Regulation
Gujarat's Food & Drug Control Agency (FDCA) oversees the manufacturing and sales of food, drugs, and cosmetics. The FDCA is the organisation in charge of giving licences to parties involved in the production and sale of pharmaceuticals and related goods, such as drug makers, wholesalers, retailers, stockists, C&F agents, etc. The enforcement mission is to achieve the goal of making safe and effective medications available by ensuring that the menace of the production of fake/substandard drugs is eliminated. Access to information that is current and accurate, as well as the ability to speak with stakeholders clearly and promptly, are essential for enforcement actions. The enforcement task was dependent on manual methods before the initiative to incorporate software, SMS notifications, etc. The initiative “DMLA- Drugs Manufacturing License Allocation” is a web based IT solution, http://dmla.guj.nic.in/mfg/myaccount/Home.aspx, with data stored in the central server. The introduction of the new system has strengthened the enforcement function. It has helped to achieve and maintain FDCA's leadership in drug regulation in India by bringing consistency, speed, accuracy, effectiveness, accountability, and transparency to G2G, G2C, and G2B operations.
2. Food & Drugs Control Administration, Gujarat; Drugs Manufacturing Licence (Allopathic) - DMLA [Internet]. Gujarat: FDA, Govt. Of Gujarat; 2023 [cited 2023 Apr 05]. Available from:
3. Food & Drugs Control Administration, Gujarat; Industry Portal for Drugs Manufacturing Licence (Allopathic)-IDMLA [Internet]. Gujarat: FDA, Govt. Of Gujarat; 2023 [cited 2023 Apr 05]. Available from:
4. Gujarat State Wide Area Network (GSWAN) [Internet]. Gujarat: Govt. Of Gujarat; 2004 Feb 28 [cited 2023 Apr 05]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM